A commonly used anti-inflammatory treatment has been added to the Randomised Evaluation of COVid-19 thERapY (RECOVERY) study, the world’s largest clinical trial of treatments for patients hospitalized with COVID-19.
Read More
![](https://covid19.healthcare.pro/wp-content/uploads/2020/11/camilo-jimenez-vGu08RYjO-s-unsplash.jpg)
A commonly used anti-inflammatory treatment has been added to the Randomised Evaluation of COVid-19 thERapY (RECOVERY) study, the world’s largest clinical trial of treatments for patients hospitalized with COVID-19.
Read More